Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Thomas

Showing results (221-230 of 300) with videos related to

Pageof 30
Sort By:
Medicine and Science in Sports and Exercise|December 7, 2017
Acute Inflammatory Responses to Exercise in Patients with Abdominal Aortic AneurysmMark Thomas Windsor, Tom George Bailey, Maria Perissiou, et al.
Clinical Transplantation|March 15, 2008
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroidsAdele H Rike, Gautham Mogilishetty, Rita R Alloway, et al.
Emerging Infectious Diseases|August 23, 2022
Fetal Loss and Preterm Birth Caused by Intraamniotic Haemophilus influenzae Infection, New ZealandThomas Hills, Caitlin Sharpe, Thomas Wong, et al.
Cancer Chemotherapy and Pharmacology|May 21, 2021
Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participantsKen Ogasawara, Jeanelle Kam, Mark Thomas, et al.
International Journal of Molecular Sciences|January 11, 2022
Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High ShearGina Perrella, Samantha J Montague, Helena C Brown, et al.
The New Zealand Medical Journal|October 25, 2013
HIV screening in New Zealand: time for a changeNick Gow, Simon Briggs, Judy Gilmour, et al.
Current Hypertension Reports|March 29, 2017
Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?Hamish Cg Prosser, Cynthia Gregory, Dagmara Hering, et al.
Chemistry & Biology|February 24, 2006
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug designGeorge Kontopidis, Campbell McInnes, Sravan R Pandalaneni, et al.
Journal of the American Chemical Society|May 2, 2012
Interplay of metalloligand and organic ligand to tune micropores within isostructural mixed-metal organic frameworks (M'MOFs) for their highly selective separation of chiral and achiral small moleculesMadhab C Das, Qunsheng Guo, Yabing He, et al.
Kidney & Blood Pressure Research|September 29, 2024
Assessing the Sympatholytic Effects of SGLT2 Inhibitors in Anuric Haemodialysis Patients Using Microneurography: Study Protocol for a Mechanistic Proof-of-Concept TrialAaron Yee Shuen See, Evgenija Blazeska, Awf Abdulrahman Shaban, et al.
Pageof 30

Showing results (221-230 of 300) with videos related to

Sort By:
Pageof 30
Medicine and Science in Sports and Exercise|December 7, 2017
Acute Inflammatory Responses to Exercise in Patients with Abdominal Aortic AneurysmMark Thomas Windsor, Tom George Bailey, Maria Perissiou, et al.
Clinical Transplantation|March 15, 2008
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroidsAdele H Rike, Gautham Mogilishetty, Rita R Alloway, et al.
Emerging Infectious Diseases|August 23, 2022
Fetal Loss and Preterm Birth Caused by Intraamniotic Haemophilus influenzae Infection, New ZealandThomas Hills, Caitlin Sharpe, Thomas Wong, et al.
Cancer Chemotherapy and Pharmacology|May 21, 2021
Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participantsKen Ogasawara, Jeanelle Kam, Mark Thomas, et al.
International Journal of Molecular Sciences|January 11, 2022
Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High ShearGina Perrella, Samantha J Montague, Helena C Brown, et al.
The New Zealand Medical Journal|October 25, 2013
HIV screening in New Zealand: time for a changeNick Gow, Simon Briggs, Judy Gilmour, et al.
Current Hypertension Reports|March 29, 2017
Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?Hamish Cg Prosser, Cynthia Gregory, Dagmara Hering, et al.
Chemistry & Biology|February 24, 2006
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug designGeorge Kontopidis, Campbell McInnes, Sravan R Pandalaneni, et al.
Journal of the American Chemical Society|May 2, 2012
Interplay of metalloligand and organic ligand to tune micropores within isostructural mixed-metal organic frameworks (M'MOFs) for their highly selective separation of chiral and achiral small moleculesMadhab C Das, Qunsheng Guo, Yabing He, et al.
Kidney & Blood Pressure Research|September 29, 2024
Assessing the Sympatholytic Effects of SGLT2 Inhibitors in Anuric Haemodialysis Patients Using Microneurography: Study Protocol for a Mechanistic Proof-of-Concept TrialAaron Yee Shuen See, Evgenija Blazeska, Awf Abdulrahman Shaban, et al.
Pageof 30